-
Global Pharmacovigilance
-
Global Pharmacovigilance50 years of pharmacovigilance
A beginner's guide to pharmacovigilance
-
WHO Programme for International Drug MonitoringBeing a member
Join the WHO Programme
WHO programme members
Country guidelines
Resources and support
The story of UMC and the WHO programme
-
Pharmacovigilance communicationsUppsala Reports magazine
Drug Safety Matters podcast
#MedSafetyWeek
Take&Tell
Annie & Mac’s Adventures
Drugs and Bugs
-
PublicationsUMC publications
WHO publications
Glossary
-
ConferencesWHO programme annual meeting
Uppsala Forum
-
VigiFlowAbout VigiFlow
Training materials
Documents and news
Vaccine surveillance in VigiFlow
-
COVID-19How to report ICSRs for COVID-19 treatments
How to find ICSRs related to COVID-19 in VigiLyze
How to understand data on side effects
-
- Research & Scientific Development
- Education & Training
-
WHODrug
-
WHODrug portfolioWHODrug Global
WHODrug Standardised Drug Groupings (SDGs)
WHODrug Koda
WHODrug Cross Reference ATC 5
WHODrug CRT Japan
WHODrug Vendor Programme
WHODrug Link Korea
-
SubscriptionSubscription fees criteria
WHODrug Subscription Inquiry
Subscription Types
How to subscribe
License Validation Service
WHODrug Access Manager
-
TrainingOnline WHODrug Training
Webinars
Videocasts
Custom training
-
Access toolsDownload Area
WHODrug CAT
WHODrug Change Request
WHODrug Insight
WHODrug User Area
-
User Group Meetings -
Dictionary data upgradingUpgrading from WHODrug Enhanced to WHODrug Global
B3/C3 formats upversioning
-
Documents and NewsWhat’s New 2021
WHODrug Newsletter 2021
News Archive
-
- VigiBase
- About Us
